FTXH vs SPY

AFTXH

BSPY

Measures won3–3level · of 6 · 5Y

$10,000 · 5Y$17,862FTXH · SPY $17,358

Lowest cost0.09%SPY · $9 on $10k

Most income1.01%SPY · $101 on $10k

Smallest drop−7.5%FTXH · worst fall in 1Y

Held in common6.1%FTXH and SPY

First Trust Nasdaq Pharmaceuticals ETF · $1.2BState Street SPDR S&P 500 ETF · $778B

+23.7%3 years · per year$18,929 · $17,888+21.4%

+12.3%5 years · per year$17,862 · $17,358+11.7%

0.60%Expense ratio$60 · $9 on $10k · lower wins0.09%

0.65%12-mo yield$65 · $101 on $10k1.01%

End-of-day Nov 10, 2026 · $10,000 5 years ago, dividends reinvested · ● winner of the row · each row scaled to the bigger of the two

5Y2 funds

#			Trend
1	AFTXH	First Trust Nasdaq Pharmaceuticals ETFRead Desk		0.60%	0.65%	+2.2%	+35.3%	+48.0%	+23.7%	+12.3%	−7.5%	$1.2B
2	BSPY	State Street SPDR S&P 500 ETFRead Desk		0.09%	1.01%	−0.4%	+10.8%	+13.0%	+21.4%	+11.7%	−8.9%	$777.9B

End-of-day Nov 10, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus

5Y2 funds

#			Trend
1	AFTXH	First Trust Nasdaq Pharmaceuticals ETFRead Desk		0.60%	0.65%	+2.2%	+35.3%	+48.0%	+23.7%	+12.3%	−7.5%	$1.2B
2	BSPY	State Street SPDR S&P 500 ETFRead Desk		0.09%	1.01%	−0.4%	+10.8%	+13.0%	+21.4%	+11.7%	−8.9%	$777.9B

End-of-day Nov 10, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus

Cards for this view

FTXH

First Trust Nasdaq Pharmaceuticals

$17,862

SPY

SPDR S&P 500

$17,359

Loading…